148 related articles for article (PubMed ID: 23602834)
1. Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer.
Khan Z; Bisen PS
Biochim Biophys Acta; 2013 Aug; 1836(1):123-45. PubMed ID: 23602834
[TBL] [Abstract][Full Text] [Related]
2. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
4. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
[TBL] [Abstract][Full Text] [Related]
5. Advances in the biology of oral cancer.
Tsantoulis PK; Kastrinakis NG; Tourvas AD; Laskaris G; Gorgoulis VG
Oral Oncol; 2007 Jul; 43(6):523-34. PubMed ID: 17258495
[TBL] [Abstract][Full Text] [Related]
6. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
7. Proliferative and apoptotic responses in cancers with special reference to oral cancer.
Kamer AR; Krebs L; Hoghooghi SA; Liebow C
Crit Rev Oral Biol Med; 1999; 10(1):58-78. PubMed ID: 10759427
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways.
Ghose A; Fleming J; El-Bayoumy K; Harrison PR
Cancer Res; 2001 Oct; 61(20):7479-87. PubMed ID: 11606383
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition and apoptosis-inducing effects of cudraflavone B in human oral cancer cells via MAPK, NF-κB, and SIRT1 signaling pathway.
Lee HJ; Auh QS; Lee YM; Kang SK; Chang SW; Lee DS; Kim YC; Kim EC
Planta Med; 2013 Sep; 79(14):1298-306. PubMed ID: 23881456
[TBL] [Abstract][Full Text] [Related]
10. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
11. A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death.
Khan S; Chib R; Shah BA; Wani ZA; Dhar N; Mondhe DM; Lattoo S; Jain SK; Taneja SC; Singh J
Eur J Pharmacol; 2011 Jun; 660(2-3):241-8. PubMed ID: 21440536
[TBL] [Abstract][Full Text] [Related]
12. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and microRNA aberrations in cancer.
Li C; Hashimi SM; Good DA; Cao S; Duan W; Plummer PN; Mellick AS; Wei MQ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):739-46. PubMed ID: 22409455
[TBL] [Abstract][Full Text] [Related]
14. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.
Ribeiro FA; Noguti J; Oshima CT; Ribeiro DA
Anticancer Res; 2014 Apr; 34(4):1547-52. PubMed ID: 24692681
[TBL] [Abstract][Full Text] [Related]
15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
[TBL] [Abstract][Full Text] [Related]
17. Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture.
Roberg K; Ceder R; Farnebo L; Norberg-Spaak L; Grafström RC
Differentiation; 2008 Oct; 76(8):868-80. PubMed ID: 18452551
[TBL] [Abstract][Full Text] [Related]
18. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
19. Isoliquiritigenin 2'-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1.
Lee YM; Jeong GS; Lim HD; An RB; Kim YC; Kim EC
Toxicol In Vitro; 2010 Apr; 24(3):776-82. PubMed ID: 20040371
[TBL] [Abstract][Full Text] [Related]
20. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.
Maddika S; Ande SR; Panigrahi S; Paranjothy T; Weglarczyk K; Zuse A; Eshraghi M; Manda KD; Wiechec E; Los M
Drug Resist Updat; 2007; 10(1-2):13-29. PubMed ID: 17303468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
